Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021)

Agios Pharmaceuticals (AGIO) has disclosed Divestments for 2 consecutive years, with $1.8 billion as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Divestments rose 695080.69% year-over-year to $1.8 billion, compared with a TTM value of -$455000.0 through Mar 2022, down 100.03%, and an annual FY2024 reading of $200.0 million, changed N/A over the prior year.
  • Divestments was $1.8 billion for Q1 2021 at Agios Pharmaceuticals, up from -$455000.0 in the prior quarter.
  • Across five years, Divestments topped out at $1.8 billion in Q1 2021 and bottomed at -$455000.0 in Q4 2020.